Shares in biotechnology, life sciences, and diagnostics company Danaher (NYSE: DHR) rose by as much as 12.9% in early morning ...

It is financial reporting season, and a few major medtech companies posted third-quarter sales growth. | It is financial ...

Discover Danaher Q3 2025 earnings call insights—revenue growth, margin expansion, and 2026 targets. Get key financial and market outlook.

Danaher stock surged over 7% on Tuesday after the company delivered a solid third-quarter performance, with revenues rising 4 ...

Danaher Corporation ( NYSE: DHR) Q3 2025 Earnings Call October 21, 2025 8:00 AM EDT ...

Danaher Corp (DHR) reports robust Q3 performance with $6.1 billion in sales, a 10% increase in adjusted EPS, and a $2 billion ...

In Q3, Danaher reported adjusted EPS of $1.89, up from $1.71 in the same quarter last year. This print beat analysts’ ...

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended September 26, 2025.

Diagnostic testing in modern medicine remains largely episodic and threshold-based. Episodic can be defined as tests taken at discrete points of time where the result is viewed in that moment of time ...

Siemens Healthineers AG is holding preliminary talks with several major private equity firms about the potential sale of its diagnostics division for 6 billion euros ($7 billion) and above. This is ...

The IAEA has recently published the ‘Diagnostic Radiology Physics: A Handbook for Teachers and Students’, aiming at providing the basis for the education of medical physicists initiating their ...